While the mechanism for compensating people who have had AEFI during a clinical trial is present, there is no such formal system for compensation when a vaccine is in the market.
from Today's Paper https://ift.tt/33A3e45
from Today's Paper https://ift.tt/33A3e45
Comments
Post a Comment